Hippocampal Stimulation in Chronic Low Back Pain
- Conditions
- Chronic PainBack PainPain
- Interventions
- Device: Transcranial Magnetic StimulationDevice: Sham rTMS
- Registration Number
- NCT04888494
- Lead Sponsor
- Northwestern University
- Brief Summary
In this study the investigators aim to examine the effects of Transcranial Magnetic Stimulation (TMS) on hippocampal network connectivity and pain levels in individuals with chronic low back pain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
- ≥ 6 months of back pain on a daily basis;
- male or female with no racial or ethnic restrictions;
- 18 to 75 years old;
- average back pain intensity > 4/10 at study entry;
- must be able to read, understand, and sign consent form;
- generally healthy.
- back pain with fever, chills, rheumatoid arthritis, ankylosing spondylitis, acute vertebral fractures,
- history of tumor in the back;
- back surgery within the past 6 months;
- Chronic neurologic conditions, e.g., Parkinson's
- involvement in litigation regarding back pain;
- other severe medical diseases;
- pregnancy;
- positive urinary screen for any recreational drugs,
- opioids use;
- use of anticoagulants (low dose ASA allowed);
- history of gastric ulcer; renal insufficiency or congestive heart failure,
- contraindication to MRI,
- contraindication to TMS; including history of seizure/epilepsy*
- Any medical condition that in the investigator's judgment may prevent the individual from completing the study or put the individual at undue risk;
- In the judgment of the investigator, unable or unwilling to follow protocol and instructions;
- Diagnosis of major depression;
- Intra-axial implants (e.g. spinal cord stimulators or pumps)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Hippocampus-stimulation Transcranial Magnetic Stimulation Active high-frequency rTMS (20 Hz pulse trains) Sham-stimulation Sham rTMS Sham rTMS
- Primary Outcome Measures
Name Time Method Changes in Pain Scales Pain is assessed at baseline, end of first intervention and end of the second intervention. The endpoint will be the severity of pain measured by changes in the Numeric Rating Scale (NRS) scores before and after each stimulation round. The NRS is a pain screening tool that assesses pain severity during assessment using a 0-10 scale, where zero means "no pain" and ten means "the worst pain imaginable." Higher values indicate a worse outcome.
- Secondary Outcome Measures
Name Time Method Changes in Hippocampal Connectivity approximately 6 weeks - Baseline and after the end of hippocampal stimulation Changes in hippocampal network connectivity will be evaluated by using resting state functional magnetic resonance (fMRI) before and after hippocampal stimulation. Hippocampal connectivity measurements - regions involved in the network and the parietal target - will be compared before stimulation (baseline) to after stimulation (after active hippocampal stimulation).
Trial Locations
- Locations (1)
Northwestern University Feinberg School of Medicine
🇺🇸Chicago, Illinois, United States